Clinical Trial Update: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating bevacizumab in patients with ovarian cancer or primary peritoneal cancer after f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED